Tissue model reveals how RNA will act on the liver
Studies could speed the development of new treatments for liver disease.
A better way to measure cell survival
New test rapidly evaluates the effect of drugs and potentially toxic compounds on cells.
Julia Lab joins team to speed up drug approval process
Health Analytics Collective uses real-world evidence to modernize health and drug development decisions.
Stephen Buchwald awarded 2019 Wolf Prize for chemistry
Honor shared with John Hartwig of the University of California at Berkeley for their development of a process to improve the synthesis of large organic molecules.
MIT engineers repurpose wasp venom as an antibiotic drug
Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.
Chemical synthesis could produce more potent antibiotics
Simple method for linking molecules could help overcome drug resistant infections.
Cryptographic protocol enables greater collaboration in drug discovery
Neural network that securely finds potential drugs could encourage large-scale pooling of sensitive data.
Computer model offers more control over protein design
New approach generates a wider variety of protein sequences optimized to bind to drug targets.
A new way to manufacture small batches of biopharmaceuticals on demand
System can be rapidly reconfigured to produce a variety of protein drugs.
Plug-and-play technology automates chemical synthesis
System makes it easier to produce new molecules for myriad applications.
Sensor could help doctors select effective cancer therapy
Hydrogen peroxide-sensing molecule reveals whether chemotherapy drugs are having their intended effects.
Chemists synthesize millions of proteins not found in nature
New technology could lead to development of novel “xenoprotein” drugs against infectious diseases.
A single-injection vaccine for the polio virus
Nanoparticles could offer a new way to help eradicate the disease worldwide.
Virtual drug trials boost results
Bringing drug trials to the virtual realm, Belinda Tan ’96 has found a way to cut entire process in half.
Inaugural class of MIT-GSK Gertrude B. Elion Research Fellows selected
New fellowship program honoring trailblazing Nobel laureate awards four MIT postdocs focused on drug discovery and development.